Search Website Search Directory

UVM Cancer Center Logo

COLLEGE OF
MEDICINE
  • Home
  • About Us
    • Overview
    • Administration
    • Member Directory
    • Employment Opportunities
    • Events
    • Contact
  • For Members
    • Cancer Center Membership
    • Shared Resources
    • Clinical Trials Services
    • Extramural Funding
    • Intramural Funding
    • Transdisciplinary Teams (TDTs)
    • Protocol Review
      • Protocol Review
      • Submission Requirements
      • Procedures
      • Relationship to IRB
      • UVM Commons Tool
      • Protocol Review and Monitoring Committee Meetings
  • Clinical Care
    • Patients and Caregivers
    • Clinical Trials
      • Clinical Trials Office
      • Find A Cancer Trial
      • FAQs
      • Chemotherapy-Induced Peripheral Neuropathy Clinical Trial
  • Research
    • Research Programs
  • Community Outreach
    • Community Advisory Board
    • Public Health
    • Women's Health and Cancer Conference
  • Make a Gift
    • Give to the UVM Cancer Center
    • Ways to Give

  • UVM Cancer Center to Offer Innovative New Cancer Treatment
    February 22, 2023
    The University of Vermont Cancer Center will offer a novel, highly effective form of cancer treatment called CAR T-cell therapy, and is expected to begin treating patients in late. The Cancer Center will be the only healthcare institution in Vermont and northern New York to provide the treatment.
  • Holcombe Named Associate Dean for Cancer Programs at UVM Larner College of Medicine
    February 21, 2023
    Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.
  • Weaver & Lester-Coll Examine Impact of Health Insurance Coverage on Liver Cancer Patients
    January 31, 2023
    An analysis by UVM medical student Benjamin Weaver and UVM Cancer Center member and Assistant Professor of Radiation Oncology Nataniel Lester-Coll, M.D., illustrated both health disparities and parities across a cohort of 100,000+ patients with the most common form of liver cancer. Their results were published in the Journal of Vascular and Interventional Radiology.
  • UVM Cancer Center Welcomes Two New Colleagues: Kate Tracy and Christa Varnadoe
    January 26, 2023
  • Rally Against Cancer Winter 2023
    January 20, 2023
  • New study explores race in the association of cytopenia and cancer death
    January 12, 2023
  • Charlotte News Lauds Janssen-Heininger as a ‘Humble Superstar’
    January 12, 2023
    (JANUARY 12, 2023) Yvonne Janssen-Heininger, Ph.D., professor of pathology and laboratory medicine, is described as a “humble superstar” in an article about cancer research at UVM in The Charlotte (Vermont) News.
    Read full story from The Charlotte News
  • UVM’s Redox Researchers Collaborate with Scholars at Japan’s Tohoku University
    December 22, 2022
    Albert van der Vliet, Ph.D., professor of pathology and laboratory medicine, participated in a six-week Invited Fellowship at Tohoku University in Sendai, Japan, engaging in research on environmental medicine and molecular toxicology. The fellowship coincided with a medley of scientific meetings and symposia that brought together leading scientists from around the world in the specific research fields of nitric oxide biology. Dr. van der Vliet, Yvonne Janssen-Heininger, Ph.D., and Brian Cunniff, Ph.D. participated as invited speakers. Additional Japanese federal funding supports the exchange of invited researchers, graduate students and post-doctoral scholars to collaborate on research.
  • Lian, Stein, and Cushman Ranked Among Top Scientists in U.S.
    December 2, 2022
  • The Butler Family Foundation Fund for Cancer Research supports The Cunniff Lab in effort to discover and advance treatments for malignant mesothelioma
    November 30, 2022
  • Silver Linings: Remotely delivered exercise to older rural cancer survivors shows improved physical health
    November 19, 2022
  • Inaugural Juckett Scholars Launch Cancer Care Delivery Studies
    November 19, 2022
    The University of Vermont Cancer Center recently announced the names of the inaugural Juckett Scholars. The award program is part of the new Clinician Investigator Development Initiative and is supported by the Juckett Foundation.
  • $25,000 in seed funding awarded for “Spatialomics and Precision Medicine Pipeline” at UVM Cancer Center Scientific Retreat
    November 19, 2022
  • Innovative Approaches Hold Promise for Improving Rural Health Across Region
    November 17, 2022
    Located in a rural state with a population among the oldest in the nation, the Larner College of Medicine has long been committed to finding innovative ways to provide and improve access to health care for not only the elderly, but also all residents, regardless of location or socioeconomic status. Several research initiatives at the college focus on new approaches to help patients in these regions.
  • Cancer Center's Sajisevi & Colleagues Find Most Thyroid Cancers Detected in Asymptomatic Patients
    November 9, 2022
    Assistant Professor of Surgery Mirabelle Sajisevi, M.D., and colleagues published a study in JAMA Otolaryngology - Head and Neck Surgery regarding geographical variation in modes of detection for thyroid cancer, a disease that has risen dramatically in incidence since the 1990s.
  • Dittus, Sikorski Comment on UVM Cancer Center Being Named Health.com’s Innovative Hospital Award Winner for 2022
    November 8, 2022
    (NOVEMBER 8, 2022) Medical oncologist Kim Dittus, M.D., Ph.D., associate professor of medicine and director of the UVM Cancer Center’s Steps to Wellness exercise program for cancer survivors, was interviewed for a story about the Cancer Center being named Health.com’s Innovative Hospital Award Winner for 2022. Also interviewed was cancer survivor Evelyn Sikorski, manager of UVMMC’s employee health and wellness and employee assistance programs.
    Read full story from Health.com
  • Janssen-Heininger Probes Oxygen's Mysteries to Find Lung Disease Treatments
    October 31, 2022
    While oxygen is critical for the chemical reactions our cells need to survive, some oxygen reactions occur at the wrong locations or in the wrong proteins, which can cause damage leading to illness and death. The Yvonne Janssen-Heininger lab team has discovered new tools for determining oxidation targets, designing precise small molecules to treat lung fibrosis and cancer.
  • Celebrating Larner’s Newest Facility: The Firestone Medical Research Building
    October 28, 2022
    On October 27, 2022, the UVM Larner College of Medicine held a grand opening and dedication of the newest addition to the medical campus: the Firestone Medical Research Building.
  • “Convergence” Event Brings Global Cancer Treatment Experts, Local Students to Campus
    October 27, 2022
    A national cancer research event called Convergence brought experts from around the country and the world to the University of Vermont October 24-27 to discuss interdisciplinary techniques to advance cancer treatment. The experts, along with UVM Cancer Center faculty, presented information about their cutting-edge cancer research.
  • NBC5 Covers Cancer Convergence Conference, Quotes Holcombe
    October 27, 2022
    (OCTOBER 27, 2022) NBC5, WCAX, and other media covered the annual Cancer Convergence Conference, which brought experts from around the country and the world to UVM and featured a Careers in Cancer event for local high school students.
  • 1 (current)
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
News Sources
  • University of Vermont Medical Center
  • Larner College of Medicine News
Tweets by UVM Cancer Center
Accessibility | Privacy/Terms of Use
Copyright 2023 | Burlington, VT